High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India
Hämostaseologie · 01.04.2023 · 43 (02) · 126-131
DOI: 10.1055/a-1733-2143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.04.2023. Verfasst von Ann Maria Tony und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India. Hauptthemen laut MEDLINE: Venous Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Venous thromboembolism (VTE) is a multifactorial clotting disorder in which inherited and environmental factors synergistically contribute to its pathogenesis. The aim of this case–control study was to analyze the prevalence of hereditary thrombophilic risk factors, provoking and non-provoking environmental risk factors in patients with VTE from Kerala, India. We have observed a low prevalence of factor V Leiden (7%), prothrombin G20210A (2%), and prothrombin G20030A (2%) mutations and a high prevalence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G (52%), PAI-1 4G/4G (24%) genotypes in the VTE patients (n = 147). Deficiency of anticoagulants, antithrombin (3.4%), and protein C (4.1%) was relatively low. None of the risk factors were observed in 17% of the patients. Majority of VTE patients were younger than 50 years with a median age of 43 years. In conclusion, our results indicate a high prevalence of PAI-1 4G/5G polymorphism among the VTE patients which is in concordance with previous studies in the Asian population. The PAI-1 4G/5G polymorphism could be a potential biomarker for assessing VTE risk, particularly among the Indian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
- Department of Stroke Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
- Department of Biochemistry, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
Zitieren
APA
Tony, A. M., Vinod, V., Nambiar, V., Krishnan, S., & Biswas, L. (2023). High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India. Hämostaseologie, 43(02), 126-131. https://doi.org/10.1055/a-1733-2143
Vancouver
Tony AM, Vinod V, Nambiar V, Krishnan S, Biswas L. High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India. Hämostaseologie. 2023;43(02):126-131. doi:10.1055/a-1733-2143
BibTeX
@article{Tony2023,
author = {Tony, Ann Maria and Vinod, Vivek and Nambiar, Vivek and Krishnan, Sajitha and Biswas, Lalitha},
title = {High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India},
journal = {Hämostaseologie},
year = {2023},
volume = {43},
number = {02},
pages = {126--131},
doi = {10.1055/a-1733-2143}
}
EUVIMED